Guided Therapeutics, Inc. (GTHP)
OQB · Healthcare · Medical Devices
$0.20
+0.00%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$19.6M
Shares Outstanding
96.5M
P/S (TTM)
25.6x
Exchange
OQB
Currency
USD
About Guided Therapeutics, Inc.
Guided Therapeutics, Inc., a medical technology company, researches, develops, tests, manufactures, sells, and distributes medical devices in the United States and internationally. It offers LuViva, an advanced cervical scan non-invasive cervical cancer detection device that provides less invasive and painless alternative to conventional tests for identifying, screening, and detecting cervical cancers and precancers. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 117K | 60K | 590K | 0.00 |
| Gross Profit | 79K | 35K | 458K | 0.00 |
| Operating Income | -763K | -485K | -710K | -302K |
| Net Income | -811K | -742K | -1.2M | -500K |
| Diluted EPS | $-0.01 | $-0.01 | $nan | $-0.01 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 13K | 98K | 7K | 767K |
| Gross Profit | -68K | 36K | 2K | 571K |
| Operating Income | -3.3M | -3.5M | -2.1M | -2.4M |
| Net Income | -4.3M | -3.5M | -2.4M | -3.2M |
| Diluted EPS | $-0.15 | $-0.07 | $-0.05 | $-0.04 |